Michel Bublot

Summary

Affiliation: Merial SAS
Country: France

Publications

  1. ncbi Immunogenicity of fowlpox virus expressing the avian influenza virus H5 gene (TROVAC AIV-H5) in cats
    Kemal Karaca
    Merial Ltd, 115 Transtech Drive, Athens, Georgia 30601, USA
    Clin Diagn Lab Immunol 12:1340-2. 2005
  2. ncbi Development and use of fowlpox vectored vaccines for avian influenza
    Michel Bublot
    Merial SAS, Discovery Research, 254, rue Marcel Merieux, 69007 Lyon, France
    Ann N Y Acad Sci 1081:193-201. 2006
  3. ncbi Use of a vectored vaccine against infectious bursal disease of chickens in the face of high-titred maternally derived antibody
    M Bublot
    Biological Research and Development, MERIAL S A S, F 69007 Lyon, France
    J Comp Pathol 137:S81-4. 2007
  4. ncbi High level of protection induced by two fowlpox vector vaccines against a highly pathogenic avian influenza H5N1 challenge in specific-pathogen-free chickens
    Michel Bublot
    MERIAL S A S, R and D, 69007 Lyon, France
    Avian Dis 54:257-61. 2010
  5. ncbi Immunogenicity of poxvirus vector avian influenza vaccines in Muscovy and Pekin ducks
    Michel Bublot
    MERIAL S A S, R and D, 69007 Lyon, France
    Avian Dis 54:232-8. 2010
  6. ncbi Efficacy of two H5N9-inactivated vaccines against challenge with a recent H5N1 highly pathogenic avian influenza isolate from a chicken in Thailand
    Michel Bublot
    Merial SAS, R and D, Lyon 69007, France
    Avian Dis 51:332-7. 2007
  7. ncbi Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge
    Michel Bublot
    Merial SAS, Discovery Research, Lyon 69007, France
    Avian Dis 51:498-500. 2007
  8. ncbi Field efficacy trial of a novel HVT-IBD vector vaccine for 1-day-old broilers
    F X Le Gros
    MERIAL S A S, Laboratoire de Lyon Gerland, 254 rue Marcel Merieux, 69007 Lyon, France
    Vaccine 27:592-6. 2009
  9. ncbi Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge
    Jules M Minke
    Merial SAS, 254 rue Marcel Merieux, Lyon, 69007, France
    Am J Vet Res 68:213-9. 2007
  10. ncbi Improvements to the hemagglutination inhibition test for serological assessment of recombinant fowlpox-H5-avian-influenza vaccination in chickens and its use along with an agar gel immunodiffusion test for differentiating infected from noninfected vaccina
    David E Swayne
    Southeast Poultry Research Laboratory, Agricultural Research Service, U S Department of Agriculture, 934 College Station Road, Athens, Georgia 30605, USA
    Avian Dis 51:697-704. 2007

Collaborators

  • David E Swayne
  • David L Suarez
  • Ian H Brown
  • Olivier Guionie
  • Erica Spackman
  • F X Le Gros
  • Thierry van den Berg
  • Jules M Minke
  • Kemal Karaca
  • F Prandini
  • C Giacomini
  • M Graziani
  • A Dancer
  • L Pizzoni
  • Steven Van Borm
  • Mieke Steensels
  • Benedicte Lambrecht
  • Sylvie MarchĂ©
  • HervĂ© Coupier
  • Sonia Dinic
  • Maria C Pardo
  • Pierre-Michel Guigal
  • Jean-Christophe Audonnet
  • Jean Christophe Audonnet
  • Pierre Michel Guigal
  • Tracey Sindle
  • Caroline Edlund Toulemonde
  • David Jessett
  • Linda Black
  • Amy Robles
  • Deborah Grosenbaugh
  • Robert Nordgren

Detail Information

Publications11

  1. ncbi Immunogenicity of fowlpox virus expressing the avian influenza virus H5 gene (TROVAC AIV-H5) in cats
    Kemal Karaca
    Merial Ltd, 115 Transtech Drive, Athens, Georgia 30601, USA
    Clin Diagn Lab Immunol 12:1340-2. 2005
    ..The vaccine described in this study and other poxvirus-vectored vaccines may be of value for the prophylaxis of AI virus-associated morbidity and mortality in mammals...
  2. ncbi Development and use of fowlpox vectored vaccines for avian influenza
    Michel Bublot
    Merial SAS, Discovery Research, 254, rue Marcel Merieux, 69007 Lyon, France
    Ann N Y Acad Sci 1081:193-201. 2006
    ..TROVAC-H5 has recently been shown to be immunogenic in cats and could therefore also be considered for use in mammals...
  3. ncbi Use of a vectored vaccine against infectious bursal disease of chickens in the face of high-titred maternally derived antibody
    M Bublot
    Biological Research and Development, MERIAL S A S, F 69007 Lyon, France
    J Comp Pathol 137:S81-4. 2007
    ..These data show that the vector vaccine combines a safety and efficacy profile that cannot be achieved with classical IBD vaccines...
  4. ncbi High level of protection induced by two fowlpox vector vaccines against a highly pathogenic avian influenza H5N1 challenge in specific-pathogen-free chickens
    Michel Bublot
    MERIAL S A S, R and D, 69007 Lyon, France
    Avian Dis 54:257-61. 2010
    ..Altogether, these data show excellent levels of protection in all three vaccinated groups, and therefore no detectable effect of the origin of the inserted H5 gene on protection under these tested conditions...
  5. ncbi Immunogenicity of poxvirus vector avian influenza vaccines in Muscovy and Pekin ducks
    Michel Bublot
    MERIAL S A S, R and D, 69007 Lyon, France
    Avian Dis 54:232-8. 2010
    ..However, HI antibody titers were of short duration for both vaccine schemes, and their persistence was heterogeneous among individual birds...
  6. ncbi Efficacy of two H5N9-inactivated vaccines against challenge with a recent H5N1 highly pathogenic avian influenza isolate from a chicken in Thailand
    Michel Bublot
    Merial SAS, R and D, Lyon 69007, France
    Avian Dis 51:332-7. 2007
    ..Altogether, these data indicate that both vaccines protected very well against morbidity and mortality and reduced or prevented shedding induced by direct or contact exposure to Asian H5N1 HPAI virus...
  7. ncbi Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge
    Michel Bublot
    Merial SAS, Discovery Research, Lyon 69007, France
    Avian Dis 51:498-500. 2007
    ..Together, these results confirm the excellent level of protection induced by rFP-AIV-H5 in SPF chickens against two recent Asian HPAI H5N1 isolates...
  8. ncbi Field efficacy trial of a novel HVT-IBD vector vaccine for 1-day-old broilers
    F X Le Gros
    MERIAL S A S, Laboratoire de Lyon Gerland, 254 rue Marcel Merieux, 69007 Lyon, France
    Vaccine 27:592-6. 2009
    ..The maternal immunity interfering with the live IBDV vaccine replication had no detectable effect on the vector vaccine take...
  9. ncbi Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge
    Jules M Minke
    Merial SAS, 254 rue Marcel Merieux, Lyon, 69007, France
    Am J Vet Res 68:213-9. 2007
    ....
  10. ncbi Improvements to the hemagglutination inhibition test for serological assessment of recombinant fowlpox-H5-avian-influenza vaccination in chickens and its use along with an agar gel immunodiffusion test for differentiating infected from noninfected vaccina
    David E Swayne
    Southeast Poultry Research Laboratory, Agricultural Research Service, U S Department of Agriculture, 934 College Station Road, Athens, Georgia 30605, USA
    Avian Dis 51:697-704. 2007
    ..In conclusion, we demonstrated that the rFP-H5 vaccine allowed easy serological differentiation of infected from noninfected birds in vaccinated populations of chickens when using standard AGID and HI tests...
  11. ncbi Influenza vaccines and vaccination strategies in birds
    Thierry van den Berg
    Avian Virology and Immunology, Veterinary and Agrochemical Research Centre, 99 Groeselenberg, 1180 Brussels, Belgium
    Comp Immunol Microbiol Infect Dis 31:121-65. 2008
    ..This paper addresses these differences by reviewing the current and future influenza vaccines and vaccination strategies in birds...